News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Lumativa Raises $16.24Min Series A Funding
September 4, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Lumativa AG, a Swiss developer of anti-infectives for women's health, has raised CHF 18 million ($16.24m) in Series A funding.
Twitter
LinkedIn
Facebook
Email
Print
Startups
Europe
MORE ON THIS TOPIC
Business
Takeda’s long-term R&D head announces exit after major pipeline reorganization
September 10, 2026
·
2 min read
·
Gabrielle Masson
Drug pricing
Drugmakers cherry pick launch regions as MFN creates ‘policy environment like an earthquake’
September 10, 2026
·
4 min read
·
Annalee Armstrong
Funding
Encoded raises $275M series F for Dravet syndrome gene therapy
September 10, 2026
·
2 min read
·
Tristan Manalac
Layoffs
August biopharma layoffs impact just over 500, down 90% year over year
September 10, 2026
·
6 min read
·
Angela Gabriel